Breaking News Instant updates and real-time market news.

IOVA

Iovance Biotherapeutics

$11.02

-0.45 (-3.92%)

21:04
05/07/19
05/07
21:04
05/07/19
21:04

Iovance Biotherapeutics well positioned in T-cell therapy, says Piper Jaffray

Piper Jaffray analyst Joseph Catanzaro kept his Overweight rating and $20 price target on Iovance Biotherapeutics after its Q1 results also disclosed that 3 of its abstracts submitted to ASCO have been accepted. The analyst believes that the company's lifileucel in melanoma update has a "clear opportunity to improve", whiles its LN-145 in cervical cancer data set could be supportive of an accelerated development path. Catanzaro sees Iovance Biotherapeutics as a "best-positioned T-cell therapy" stock, with $440M in cash on hand being sufficient to fund its operations into 2022.

  • 07

    May

  • 07

    May

  • 14

    May

  • 31

    May

IOVA Iovance Biotherapeutics
$11.02

-0.45 (-3.92%)

04/01/19
HCWC
04/01/19
NO CHANGE
Target $26
HCWC
Buy
Iovance data continue to build investment case, says H.C. Wainwright
Data continue to build the investment case for Iovance Biotherapeutics, H.C. Wainwright analyst Joseph Pantginis tells investors in a research note after the company and investigators presented more molecular evidence highlighting the potential association with clinical response of having persistent tumor-infiltrating lymphocytes in the peripheral blood of cancer patients. Although these data showed a positive but not statistically significant trend, further investigations assessing multiple experimental time points could confirm these results in larger cohorts and reach significant stats, says the analyst. He looks forward to the clinical execution of cohort 4, as he believes this represents the "low hanging fruit to approval." Pantginis keeps a Buy rating on Iovance with a $26 price target.
04/03/19
HCWC
04/03/19
NO CHANGE
Target $26
HCWC
Buy
Iovance clinical updates strengthen investment thesis, says H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis says today's clinical updates from Iovance Biotherapeutics strengthen his investment thesis. The company's efforts to amend clinical programs and generate more powerful tumor-infiltrating lymphocytes therapies are each crucial for gaining market share in multiple clinical indications beyond melanoma, Pantginis tells investors in a research note titled "Important Chess Moves to Head Regulatory Agencies off at the Pass." He believes the advances Iovance is making on multiple fronts, including the clinical and commercial, should be viewed as important inflection points for the shares. The analyst keeps a Buy rating on Iovance Biotherapeutics with a $26 price target.
04/29/19
PIPR
04/29/19
INITIATION
Target $20
PIPR
Overweight
Iovance Biotherapeutics initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Joseph Catanzaro started Iovance Biotherapeutics with an Overweight rating and $20 price target. The company has "clearly demonstrated the ability to produce a cell therapy with consistent and impressive efficacy in multiple solid tumor settings," Catanzaro tells investors in a research note. He believes response rates of 30%-40% position Iovance for multiple potential approvals over the next five years that include melanoma, cervical cancer, and head and neck cancer.
04/29/19
04/29/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Iovance Biotherapeutics (IOVA) initiated with an Overweight at Piper Jaffray. 2. Tradeweb Markets (TW) initiated with a Market Perform at Wells Fargo, a Hold at Jefferies and Sandler O'Neill, an Equal Weight at Morgan Stanley and Barclays, as well as a Neutral at BofA/Merrill, Goldman Sachs, Credit Suisse, and Citi. 3. Penn Virginia (PVAC) initiated with an Outperform at Imperial Capital. 4. NGM Biopharmaceuticals (NGM) initiated with an Outperform at Cowen as well as a Buy at Goldman Sachs and Citi. 5. Silk Road Medical (SILK) initiated with an Overweight at JPMorgan, an Outperform at BMO Capital, a Buy at Stifel, and a Neutral at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

TCCO

Technical Comm Corp

$3.48

(0.00%)

17:48
05/23/19
05/23
17:48
05/23/19
17:48
Hot Stocks
Technical Comm Corp receives compliance and plan acceptance notices from Nasdaq »

Technical Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$19.20

-0.095 (-0.49%)

17:42
05/23/19
05/23
17:42
05/23/19
17:42
Hot Stocks
HP Inc. says PC growth across industry was subdued this quarter »

Continue to gain momentum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

RST

Rosetta Stone

$24.93

1.135 (4.77%)

17:38
05/23/19
05/23
17:38
05/23/19
17:38
Hot Stocks
Rosetta Stone officer Sonia Galindo sells over $107K in company shares »

Rosetta Stone officer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

CCF

Chase Corporation

$100.72

0.32 (0.32%)

17:32
05/23/19
05/23
17:32
05/23/19
17:32
Hot Stocks
Chase Corporation chairman sells 2K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNR

RenaissanceRe

$170.85

-0.34 (-0.20%)

17:24
05/23/19
05/23
17:24
05/23/19
17:24
Syndicate
Breaking Syndicate news story on RenaissanceRe »

RenaissanceRe files $750M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTIX

RTI Surgical

$4.40

-0.08 (-1.79%)

17:21
05/23/19
05/23
17:21
05/23/19
17:21
Syndicate
Breaking Syndicate news story on RTI Surgical »

RTI Surgical files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 17

    Jun

DXC

DXC Technology

$52.00

-2.5 (-4.59%)

17:21
05/23/19
05/23
17:21
05/23/19
17:21
Earnings
DXC Technology sees FY20 adjusted EPS $7.75-$8.50, consensus $9.21 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

RTIX

RTI Surgical

$4.40

-0.08 (-1.79%)

17:19
05/23/19
05/23
17:19
05/23/19
17:19
Syndicate
Breaking Syndicate news story on RTI Surgical »

RTI Surgical files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 17

    Jun

RTN

Raytheon

$179.79

-1.01 (-0.56%)

17:15
05/23/19
05/23
17:15
05/23/19
17:15
Hot Stocks
Raytheon awarded $355.49M Navy contract for AGM-88B missiles »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

DVAX

Dynavax

$6.36

(0.00%)

17:15
05/23/19
05/23
17:15
05/23/19
17:15
Hot Stocks
Breaking Hot Stocks news story on Dynavax 

Dynavax trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

COST

Costco

$248.62

-0.93 (-0.37%)

17:11
05/23/19
05/23
17:11
05/23/19
17:11
Recommendations
Costco analyst commentary  »

Baird recommends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

MYND

MYnd Analytics

$1.16

0.14 (13.73%)

17:06
05/23/19
05/23
17:06
05/23/19
17:06
Hot Stocks
MYnd Analytics director John Pappajohn purchases 200K shares of company stock »

MYnd Analytics director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBOE

Cboe Global Markets

$106.40

-1.45 (-1.34%)

17:05
05/23/19
05/23
17:05
05/23/19
17:05
Hot Stocks
Cboe Global Markets EVP Harkins sells 4.3K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGNX

MacroGenics

$18.64

0.18 (0.98%)

16:56
05/23/19
05/23
16:56
05/23/19
16:56
Hot Stocks
Integrated Core Strategies reports 5.7% passive stake in MacroGenics »

Integrated Core…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

IMRN

Immuron

$4.90

(0.00%)

16:49
05/23/19
05/23
16:49
05/23/19
16:49
Syndicate
Immuron announces offering to sell ADSs »

Immuron Limited announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROLL

RBC Bearings

$140.52

1.84 (1.33%)

16:47
05/23/19
05/23
16:47
05/23/19
16:47
Hot Stocks
RBC Bearings announces $100M share repurchase program »

RBC Bearings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 05

    Jun

DVAX

Dynavax

$6.36

(0.00%)

16:47
05/23/19
05/23
16:47
05/23/19
16:47
Hot Stocks
Dynavax to restructure to focus on vaccine business »

Dynavax Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

CNC

Centene

$55.45

-1.33 (-2.34%)

, WCG

WellCare

$274.46

-3.54 (-1.27%)

16:45
05/23/19
05/23
16:45
05/23/19
16:45
Hot Stocks
Centene, WellCare announce special meeting date, transaction to close by 1H20 »

Centene (CNC) and…

CNC

Centene

$55.45

-1.33 (-2.34%)

WCG

WellCare

$274.46

-3.54 (-1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 14

    Jun

  • 23

    Jul

DVAX

Dynavax

$6.36

(0.00%)

16:42
05/23/19
05/23
16:42
05/23/19
16:42
Hot Stocks
Breaking Hot Stocks news story on Dynavax »

Dynavax trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

DNKEY

Danske Bank

$0.00

(0.00%)

16:39
05/23/19
05/23
16:39
05/23/19
16:39
Downgrade
Danske Bank rating change at Goldman Sachs »

Danske Bank downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WD

Walker & Dunlop

$51.59

-0.92 (-1.75%)

16:39
05/23/19
05/23
16:39
05/23/19
16:39
Hot Stocks
Walker & Dunlop President Howard Smith sells $4M in company shares »

Walker & Dunlop…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TD

Toronto-Dominion

$56.01

1.05 (1.91%)

16:36
05/23/19
05/23
16:36
05/23/19
16:36
Downgrade
Toronto-Dominion rating change at National Bank »

Toronto-Dominion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

16:36
05/23/19
05/23
16:36
05/23/19
16:36
General news
Money Supply M2 Weekly Change data reported »

Week of 5/13 Money Supply…

GWGH

GWG Holdings

$15.25

0.05 (0.33%)

16:36
05/23/19
05/23
16:36
05/23/19
16:36
Hot Stocks
GWG Holdings receives noncompliance notification from Nasdaq »

GWG Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSA

National Storage

$29.80

-0.195 (-0.65%)

16:35
05/23/19
05/23
16:35
05/23/19
16:35
Hot Stocks
National Storage 'elevates' its CEO Arlen Nordhagen to Executive Chairman »

National Storage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 04

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.